Actinium Pharmaceuticals (ATNM) Return on Assets (2011 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly Return on Assets of 0.01% for Q1 2026, little changed year-over-year from 0.01% in Q1 2025, and up 21.44% quarter-over-quarter from 0.01% in Q4 2025.
Actinium Pharmaceuticals (ATNM) Return on Assets (2011 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Return on Assets for 16 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets grew to 0.01% in Q1 2026 per ATNM's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q2 2022 and bottomed at 0.01% in Q1 2025.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2023.
- On a YoY basis, Return on Assets climbed as much as 1 bps in 2022 and fell as far as 0 bps in 2022.
- Actinium Pharmaceuticals' Return on Assets stood at 0.0% in 2022, then tumbled by 76 bps to 0.01% in 2023, then dropped by 28 bps to 0.01% in 2024, then rose by 15 bps to 0.01% in 2025, then grew by 21 bps to 0.01% in 2026.
- Business Quant data shows ATNM's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 0.00% |
| 10 | Actinium Pharmaceuticals | 35.17 Mn | 35.17 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |